Chicago Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$7.88M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$2.1M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$1.46M |
| 4 |
UGIC
UGI Corporation
UGIC
|
+$1.15M |
| 5 |
NIMC
NiSource Inc. Series A Corporate Units
NIMC
|
+$793K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$14.1M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$12.5M |
| 3 |
IIVI
Coherent Corp. 6.00% Series A Mandatory Convertible Preferred Stock
IIVI
|
+$9.84M |
| 4 |
FOCS
Focus Financial Partners Inc. Class A
FOCS
|
+$8.04M |
| 5 |
SABRP
Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock
SABRP
|
+$4.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.47% |
| 2 | Technology | 16.03% |
| 3 | Consumer Discretionary | 6.43% |
| 4 | Financials | 5.63% |
| 5 | Real Estate | 2.31% |
Similar funds
Chicago Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Chicago Capital Management held 26 positions worth $37.9M, down 51% from $78.1M the previous quarter. Its ten largest holdings account for 89% of the portfolio.
Chicago Capital Management withdrew a net $44.1M in Q3 2023, closing 8 positions and reducing 5 holdings. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $14.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Chicago Capital Management opened a new position in Activision Blizzard worth $5.09M.
- Chicago Capital Management's largest Q3 2023 buy was Activision Blizzard: 86,334 shares worth $5.09M.
- Chicago Capital Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2023, an estimated $278K increase.
- Chicago Capital Management's biggest Q3 2023 reduction was iRobot, cutting an estimated $1.49M.
- Chicago Capital Management fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $14.1M.
- Chicago Capital Management's ten largest holdings make up 89% of its $37.9M portfolio in Q3 2023.
- Chicago Capital Management opened 9 new positions and closed 8 in Q3 2023.
- Chicago Capital Management's portfolio value fell 51% quarter-over-quarter to $37.9M.
Based on Chicago Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.